Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Could iPSCs Enable "Off-the-Shelf" Cell Therapy?

Cell·2019
Same author

A New Wave of Genomics for All.

Cell·2019
Same author

Microbiome Research in a Social World.

Cell·2018
Same author

Biology Gone Wild.

Cell·2017
Same author

Biology Gone Wild.

Cell·2017
Same author

Divide and Conquer.

Scientific American·2016

Related Experiment Video

Updated: May 4, 2026

An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing
10:00

An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing

Published on: May 23, 2018

18.4K

Silicon Valley Meets Biomedical Research in the Chan Zuckerberg Initiative.

Diana Crow1

  • 1Cambridge, MA.

Cell
|May 20, 2017
PubMed
Summary

The Chan Zuckerberg Initiative aims to cure, manage, or treat all diseases by funding basic science and improving biomedical technology. This ambitious goal seeks to advance human health through strategic research investments.

Area of Science:

  • Biomedical Research
  • Philanthropy
  • Disease Eradication

Background:

  • The Chan Zuckerberg Initiative (CZI) is a philanthropic organization founded by Mark Zuckerberg and Priscilla Chan.
  • CZI has set a bold objective to eradicate, manage, or treat all diseases by 2100.

Purpose of the Study:

  • To outline the strategic approach of the Chan Zuckerberg Initiative in achieving its ambitious health goals.
  • To highlight the focus on funding fundamental scientific research.
  • To identify and address critical gaps in biomedical technology development.

Main Methods:

  • The initiative plans to achieve its goals by investing in basic scientific research.
  • CZI will focus on developing and implementing advanced biomedical technologies.

More Related Videos

High Throughput Yeast Strain Phenotyping with Droplet-Based RNA Sequencing
07:55

High Throughput Yeast Strain Phenotyping with Droplet-Based RNA Sequencing

Published on: May 21, 2020

7.5K
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.6K

Related Experiment Videos

Last Updated: May 4, 2026

An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing
10:00

An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing

Published on: May 23, 2018

18.4K
High Throughput Yeast Strain Phenotyping with Droplet-Based RNA Sequencing
07:55

High Throughput Yeast Strain Phenotyping with Droplet-Based RNA Sequencing

Published on: May 21, 2020

7.5K
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.6K
  • The strategy involves identifying and bridging existing gaps in the biomedical field.

    • Main Results:

    • The initiative's primary outcome is the strategic allocation of funds towards basic science.
    • A key result is the focus on advancing biomedical technology.
    • The long-term aim is to significantly impact global health outcomes.

    Conclusions:

    • The Chan Zuckerberg Initiative's approach combines foundational research with technological innovation.
    • Their long-term vision is to revolutionize disease treatment and management.
    • This initiative represents a significant philanthropic effort to advance human health.